ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 107 participants.
Also called NCT01964196
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 107 participants
- Sponsor
- Registry
-
NCT01964196
-
- Other papers using this trial's data
- Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01964196. Randomized; quadruple masking; primary purpose treatment. Start 2013-09-17 (actual); primary completion 2015-07-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-
- Condition
- Anemia in Chronic Kidney Disease Patients Not on Dialysis
- Intervention (Drug)
- ASP1517
- Intervention (Drug)
- Placebo
- Lead sponsor
- Astellas Pharma Inc
Record details
- Record id
cardio:ct-nct01964196- Content hash
dd3104a23ef49125a39fa90ed654724c37692807332568ad854341063c772ac1